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Mesenchymal Cells Hold the Key to
Immune Cell Recruitment to and
Migration within Melanoma
Kimberley A. Beaumont1, Marcia A. Munoz1 and Wolfgang Weninger1,2,3
Samaniego et al. (this issue) report on distinct tumor-associated mesenchymal cell
(MC) populations in human melanomas. FAPCD90þ peritumoral MCs may be
involved in immune cell recruitment from the bloodstream. FAPþCD90
intratumoral MCs were associated with extracellular matrix fiber deposition,
and their numbers correlated with high immune cell infiltration. Thus, different
MC subsets modulate the cellular composition of the intratumoral and
peritumoral melanoma microenvironment.
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Solid cancers are complex tissues
composed of many specialized cell
types, both normal and malignant. The
intricate interplay between host-derived
components of tumors, collectively
known as the tumor stroma, and the
transformed cells forge the tumor micro-
environment (TME). The importance of
the TME in shaping tumor development,
progression, prognosis, and even
response to therapies has been increas-
ingly recognized. The tumor stroma has
three main components: cells of mesen-
chymal origin, such as carcinoma-
associated fibroblasts, blood and
lymphatic vessels and associated cells,
and infiltrating innate and adaptive
immune cells (reviewed in Hanahan
and Coussens, 2012).
Tumor-associated immune cells
Although most tumors arise from the
organism’s own cells, it is well accepted
that the immune system has the poten-
tial to recognize and eliminate cancer-
ous cells. How tumors escape immune
responses is the subject of ongoing
research, and many different mechanisms
have been described. One important
aspect of antitumor immunity is the
positioning of immune cells within and
around solid tumors. The mechanisms
that regulate immune cell infiltration
into the TME are incompletely under-
stood. Nevertheless, immune cell
infiltrates have been shown to both
limit and promote tumor progression,
depending on the nature of the immune
cell subtypes and their functional state.
Thus, the presence of effector T cells
(CD8þ CTL and CD4þ helper T cells) is
thought to constitute a good prognostic
indicator in several human solid
tumors, including melanoma, whereas
other immune cells, such as macro-
phages and regulatory T cells, may
promote tumor progression (reviewed
in DeNardo et al., 2010). A better
understanding of immune cell recruit-
ment into tumors is important in the
development of therapeutic and vaccine
strategies.
Recent observations using intravital
multiphoton microscopy have shown
that optimal migration of infiltrating
effector T cells is essential for antitumor
immune surveillance (Mrass et al.,
2008). As in other tissues, such as
lymph nodes, lymphocyte motility
within the TME is intimately linked to
the architecture and composition of its
extracellular matrix (ECM), and this
See related article on pg 2255 may take the form of chemokine-
driven and/or contact-guided migration
(reviewed in Friedl and Weigelin, 2008).
Although the association of migrating
T cells with ECM fibers is relatively well
established, excessive accumulation
of ECM components may also limit
access of T cells to the tumor cells and
thereby contribute to cancer progression
(Salmon et al., 2012). Thus, in-depth
characterization of the cellular and
molecular factors that regulate ECM
production in malignancy is important
for our understanding of tumor survival
and growth.
Tumor-associated mesenchymal cells
One of the major stromal cell types able
to influence tumor progression is collec-
tively known as carcinoma-associated
fibroblasts. Carcinoma-associated fibro-
blasts are thought to originate from
fibroblasts and other mesenchymal
cell (MC) types, such as pericytes
or mesenchymal stem cells, and are
characterized by the expression of the
myofibroblast marker a-smooth muscle
actin or fibroblast activation protein
(FAP) (reviewed in Polanska and
Orimo, 2013). Cancer cells are able
to recruit and stimulate the growth
of normal MCs from the surrounding
tissue, and MC phenotype and function
may coevolve with tumor progression.
Aside from their influence on cancer
cell proliferation and invasion via
secretion of growth factors/cytokines,
regulation of neoangiogenesis, and
ECM remodeling, MCs are also known
to influence both immune cell recruit-
ment and function via chemokine
secretion and alterations in the tumor
vasculature. However, a general short-
coming of investigating the different
roles of MCs in tumor biology is that
they represent a heterogenous popu-
lation; thus, a better phenotypic defini-
tion of MC subsets would be useful.
In this issue of JID, Samaniego et al.
(2013) report the characterization of
novel tumor-associated MC subsets
in primary and metastatic human
melanoma specimens based on the
expression of FAP and CD90 (cluster of
differentiation 90; Thy-1). Using elegant
multicolor immunostaining of tissue
sections, three distinct MC groups were
found: (1) FAPþCD90l0/ MCs within
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the intratumoral area; (2) FAPþCD90þ
elongated MCs within peritumoral
stroma; and (3) FAPCD90hi peri-
vascular MCs (pericytes). Whether
these different MC phenotypes are
derived from a single mesenchymal
progenitor or represent distinct MC
lineages was not investigated.
Establishment of CD90þ MC cell
lines isolated from melanoma tissues
showed that these cells secreted high
levels of CCL2 (chemokine (C–C motif)
ligand 2) compared with MCs isolated
from normal tissue. CD90þ MC cells
were able to induce CCL2-dependent
chemotaxis of monocytes and, to a
lesser extent, T lymphocytes. Most cells
expressing CCR2 (the receptor for
CCL2) in the melanoma tissues were
leukocytes in proximity to peritumoral
vessels, which suggests that leukocytes
are recruited from the blood into the
peritumoral stroma via CCL2. In addi-
tion, the density of peritumoral vessels
and CD90þ MCs correlated with
leukocyte infiltration. This is consistent
with a previous study in which micro-
vessel density in the peritumoral stroma
showed a correlation with leukocyte
abundance (Kiss et al., 2007). Never-
theless, the authors demonstrated further
that other cells in the TME also expres-
sed CCL2; therefore, it is unlikely that
the perivascular MCs were the only cells
involved in leukocyte recruitment into
the peritumoral stroma via CCL2.
The authors found further that tumor-
associated macrophages (TAMs) purified
from melanoma tissues did not express
CCR2, suggesting that leukocyte infiltra-
tion from the peritumoral region into the
tumor itself was independent of CCL2.
TAMs may downregulate CCR2, and the
authors suggest that this could relate to
macrophage differentiation triggered by
the TME. Whether T cells also show
downregulation of CCR2 in melanoma
tissues was not investigated. A previous
study in colorectal cancer described a
mechanism by which tumors are able to
escape T-cell infiltration by posttransla-
tional modification of CCL2 (nitration)
to prevent T-cell binding (Molon et al.,
2011). This may explain why T-cell
infiltration does not correlate with
CCL2 expression in melanoma.
Notably, Samaniego et al. found that
leukocyte infiltration correlated posi-
tively with both the number of FAPþ
MCs within melanomas and the extent
of the intratumoral ECM network, as
shown by staining for collagen I. Thus,
leukocyte density was significantly
lower in melanomas with low numbers
of FAPþ MCs. In addition, intratumoral
leukocytes were found to colocalize
with collagen fibers, regardless of the
density of the fiber network.
Importantly, the authors were also
able to demonstrate that co-injection of
patient-derived MCs with A375 human
melanoma cell lines into immunodefi-
cient mice resulted in the formation
of a well-organized intratumoral ECM
network when compared with tumor
cells injected alone. Moreover, only in
A375 cell–MC mixed tumors were
abundant host-derived innate immune
cells found. Elegant adoptive transfer
studies with activated CD8þ T cells
revealed an increased T-cell infiltration
into mixed tumors compared with A375
tumors. Finally, the authors showed that
integrin-dependent T-cell migration on
top of melanoma cell monolayers
in vitro was enhanced significantly
when the MCs were mixed with mela-
noma cells. Pharmacological inhibition
of chemokine receptor signaling had no
effect on T-cell motility, indicating that
the enhanced migration was most likely
chemokine independent, and was rather
contact based.
In summary, this study supports a
two-step model for immune cell recruit-
ment and infiltration in human melano-
mas (see Figure 1). Peritumoral
recruitment of immune cells is most
likely supported by chemokine-secreting
perivascular CD90þ MCs. By contrast,
infiltration of leukocytes into the mela-
noma itself requires the presence of
FAPþ , ECM-producing MCs that gener-
ate a permissive environment for cell
invasion and migration.
Concluding remarks
This study corroborates the potential of
MCs to serve as therapeutic targets or
prognostic indicators in melanoma.
Previous work in murine cancer models
showed that targeting FAPþ stromal
cells (by immunotherapy or ablation)
would reduce tumor growth successfully
by eliciting an antitumor immune
response (Lee et al., 2005; Kraman
et al., 2010). Targeting pericytes has
also been tested in various cancer
models, but whether such a strategy
slows tumor progression is still
uncertain (reviewed in Armulik et al.,
2011).
Although the data in this study have
advanced our understanding of the role
of MCs in leukocyte recruitment to
the melanoma microenvironment, the
authors did not investigate whether the
number of FAPþ MCs or ECM network
density correlated with clinical out-
come. They propose that melanomas
can be classified into those with high
intratumoral MC and leukocyte numbers
as opposed to tumors that are low
in both cell populations, and it will be
important to determine whether the
number of intratumoral MCs could be
used as a prognostic factor. The most
abundant immune cells associated with
FAPþ MCs were TAMs, followed by
CD8þ T cells. CD8þ T-cell abundance
correlates with a positive clinical out-
come in a variety of malignancies,
Clinical Implications
 The tumor stroma in melanoma includes MCs with diverse and even
competing capabilities.
 These MC subsets modulate the composition of infiltrating leukocytes
into the intratumoral and peritumoral microenvironment.
 Importantly, leukocytes recruited into the tumor by these cells may
compete by promoting or preventing its survival.
 Thus, therapies that inhibit or promote the activities of MCs in a selective
manner may ultimately become useful therapeutic tools.
 In sum, this study corroborates the potential of MCs to serve as
therapeutic targets or prognostic indicators in melanoma.
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including melanoma (Erdag et al.,
2012), whereas the presence of TAMs
(in particular, alternatively activated M2
macrophages) is generally indicative of
poor prognosis (Jensen et al., 2009).
Future studies will have to characterize
the relationships among intratumoral
MCs, ECM fibers, TAMs, T cells, and
clinical outcome.
Another important question is the
lineage relationship of the individual
MC populations, i.e., whether they
arise from the same precursor or are
unrelated. In addition, factors in the
TME that activate MCs to produce
chemokines and ECM components will
need to be analyzed in greater detail.
A clearer understanding of the role the
stroma has in tumor progression is
required not only to design improved
and safer anticancer therapies, but also
to identify better indicators of treatment
responsiveness and prognosis.
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Figure 1. Immune cell recruitment and infiltration into melanoma tumors. Illustration of the potential
involvement of MCs in immune cell melanoma infiltration as identified by Samaniego et al. (2013). Step 1
represents the recruitment of immune cells from the blood into the peritumoral region. FAPCD90þ
perivascular mesenchymal cells (MCs) may release chemokines, such as CCL2 (chemokine (C–C motif)
ligand 2), to assist in this process. Step 2 is immune cell infiltration from peritumoral regions into
the tumor guided by intratumoral FAPþCD90 MCs and extracellular matrix (ECM) fibers. CD90,
cluster of differentiation 90; FAP, fibroblast activation protein; TAM, tumor-associated macrophage.
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